Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SON-1010 by Sonnet BioTherapeutics for Mesenchymal Tumor: Likelihood of Approval
SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Mesenchymal Tumor. According to GlobalData, Phase...
Data Insights
SON-1010 by Sonnet BioTherapeutics for Head And Neck Cancer: Likelihood of Approval
SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Head And Neck Cancer. According to...